Physician

Diego Mastronardi, M.D.

According to 2025 Medicare claims, Diego Mastronardi, M.D. (NPI: 1104822626) practices family practice in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-1759. Mastronardi is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Mastronardi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 391 traditional Medicare patients, billed 23,013 HCPCS/CPT codes, and received $236,222 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,507 prescription claims across 386 beneficiaries totaling $806,055 in drug costs, led by Ozempic (Semaglutide). DME data shows 69 claims. Open Payments data shows 71 records totaling $88,495. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $136,477 to $236,222. Similarly, Part D prescription costs have risen steadily, from $489,215 to $806,055. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,255 and ending at $10,185.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	239	6,145	$136,477
2016	248	6,366	$141,597
2017	257	7,206	$142,527
2018	252	9,518	$151,887
2019	264	11,646	$168,434
2020	382	17,998	$173,330
2021	484	18,488	$194,867
2022	385	27,422	$189,780
2023	454	23,838	$222,026
2024	391	23,013	$236,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	285	5,455	$489,215
2016	289	5,278	$466,253
2017	302	5,637	$451,775
2018	307	5,557	$451,961
2019	314	5,944	$460,958
2020	345	6,401	$535,026
2021	356	5,990	$482,002
2022	353	5,918	$559,920
2023	356	6,353	$718,231
2024	386	7,507	$806,055

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	42	158	$5,848
2016	40	155	$2,535
2017	70	165	$5,196
2018	37	108	$1,304
2019	42	146	$3,240
2020	34	86	$1,091
2021	16	67	$739
2022	14	57	$879
2023	N/R	42	$3,673
2024	N/R	69	$7,647

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	197	540	$75
84443	Blood test, thyroid stimulating hormone (tsh)	196	298	$16
80061	Blood test, lipids (cholesterol and triglycerides)	209	469	$13
80053	Blood test, comprehensive group of blood chemicals	232	603	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	228	545	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	149	4,494	$139,311
Synjardy Xr	Empagliflozin/Metformin Hcl	61	3,780	$72,640
Trulicity	Dulaglutide	49	2,212	$69,059
Eliquis	Apixaban	53	2,670	$50,946
Jardiance	Empagliflozin	58	2,692	$46,860

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	16	$7,317
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	24	$222
E0570	Nebulizer, with compressor	Y	N/R	29	$108

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,169	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$87,326	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Diego Mastronardi, M.D.?

Tedicare shows public-source Medicare data for Diego Mastronardi, M.D. (NPI 1104822626), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Diego Mastronardi, M.D. have ACO affiliation data?

Diego Mastronardi, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Diego Mastronardi, M.D.?

Diego Mastronardi, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Diego Mastronardi, M.D. have Open Payments data?

Diego Mastronardi, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.